Shockwave stent trial pulled before it began

NCT ID NCT05147363

Terminated Disease control Sponsor: Cardiovascular Institute of the South Clinical Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to test a special shockwave device that uses sound waves to crack calcium buildup in leg arteries before placing a stent. The goal was to improve stent fit and long-term blood flow in people with severe peripheral artery disease. However, the trial was withdrawn before enrolling any participants, so no data was collected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Shockwave Intravenous Lithotripsy device with a Supera stent
What this could lead to: If it had worked, this approach could have improved stent success and long-term blood flow in leg arteries, reducing the need for repeat procedures.
What could go wrong: The trial was withdrawn before any participants were enrolled, so no results are available. The procedure also carries risks like vessel injury or heart events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Locations

Cardiovascular Institute of the South

Houma, Louisiana, 70360, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.